UK markets open in 3 hours 42 minutes

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
333.01-0.60 (-0.18%)
At close: 4:00PM EDT
336.50 +3.49 (+1.05%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close333.61
Bid336.50 x 800
Ask336.99 x 900
Day's range329.39 - 338.60
52-week range65.49 - 497.49
Avg. volume17,260,740
Market cap134.418B
Beta (5Y monthly)1.49
PE ratio (TTM)39.34
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Editor's pick
    Yahoo Finance Video

    Doctor on Covid-19: ‘This is a virus that is really here to stay’

    Dr. Elizabeth Clayborne, Adjunct Assistant Professor of Emergency Medicine at the University of Maryland School of Medicine and Emergency Physician at UM Capital Region Medical Center, joins Yahoo Finance to discuss the latest in the coronavirus pandemic.

  • Motley Fool

    Here's Why Moderna's Growth May Be Just Getting Started

    Moderna (NASDAQ: MRNA) stock might look a bit expensive these days. At the same time, some investors wonder whether Moderna may have reached peak sales of its coronavirus vaccine. Right now, it's too early to predict if and when coronavirus vaccine sales will slow.

  • Motley Fool

    3 Biotech Stocks That Are Ridiculously Overpriced

    Beauty is in the eye of the beholder -- and, in many cases, so is the appropriate valuation of a stock. Here's why they picked Cassava Sciences (NASDAQ: SAVA), Ocugen (NASDAQ: OCGN), and Moderna (NASDAQ: MRNA). Prosper Junior Bakiny (Cassava Sciences): Investors have been flocking to this clinical-stage biotech all year long, pushing its share price up by well over 600%.